ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1639

Concordance of Self-Reported Physical Functioning and Physical Performance in SLE: A Cross-Cohort Analysis

Laura Plantinga1, Mrinalini Dey2, Jessica Fitzpatrick3, Maria Dall'Era4, Charmayne Dunlop-Thomas5, Courtney Hoge5, S. Sam Lim6, C. Barrett Bowling7, Jinoos Yazdany3 and Patti Katz8, 1University of California, San Francisco, San Francisco, CA, 2Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 3UCSF, San Francisco, CA, 4Division of Rheumatology, University of California, San Francisco, CA, 5Emory University, Atlanta, GA, 6Emory University School of Medicine, Atlanta, GA, 7Duke University, Durham, NC, 8UCSF, San Rafael, CA

Meeting: ACR Convergence 2025

Keywords: Aging, physical function, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1633–1649) ARP Posters II: ARP Epidemiology & Public Health

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Assessment of self-reported physical functioning is common in SLE and essential for high-quality SLE care. However, because many factors may influence self-reported physical function (individual’s perceptions of physical abilities and limitations), it may be an imperfect measure of physical performance (observations of physical function). We leveraged two adult population-based SLE cohorts with simultaneous assessments of self-reported (perceived) physical function and physical performance to estimate the concordance of these measures and explore the factors associated with discordance.

Methods: Cross-sectional data on perceived physical function [Patient-Reported Outcomes Measurement Information System Physical Function (PROMIS PF) 10a or 10b, both reported as T-scores (population mean = 50, SD = 10)] and physical performance [Short Physical Performance Battery (SPPB; score range: 0–12, higher scores = better performance on balance, gait speed, and chair stand tasks)] and were obtained from Approaches to Positive, Patient-centered Experiences of Aging with Lupus (APPEAL; 10/2019–5/2022) and California Lupus Epidemiology Study (CLUES; 1/2018–9/2019). We assessed concordance between quartiles of PROMIS PF and SPPB scores and the factors associated with discordant (³2 quartiles different) vs. concordant scores using crude multinomial logistic regression.

Results: Among 619 participants (mean age, 46; 91% female; 13% Asian, 61% Black, 11% Hispanic, 14% White), mean PROMIS PF and SPPB scores were 41 and 9, respectively. Percent agreement between quartiles of SPPB and PROMIS PF scores was 37% (Figure 1). Overall, 478 individuals had concordant scores (77%), while the remaining 23% had discordant scores: 69 (11%) with SPPB score > PROMIS PF score and 72 (12%) with SPPB score < PROMIS PF score. Higher BMI and disease activity were associated with 18% and 42% higher relative risk of discordant scores with SPPB > PROMIS PF (vs. concordant); in contrast, higher disease activity and depressive symptoms were associated with 62% and 42% lower relative risk of discordant scores with SPPB < PROMIS PF (vs. concordant) (Table 1). Higher coping efficacy scores were associated with 9% lower and 19% higher risk of discordant scores with SPPB > PROMIS PF and SPPB < PROMIS PF, respectively. Patient-reported pain, sleep problems, and fatigue were associated with 1.4- to 2.0-fold higher risk of discordant scores with SPPB > PROMIS PF (not statistically significant) and 40-60% lower risk of discordant scores SPPB < PROMIS PF.

Conclusion: In this large, cross-cohort analysis, nearly one-quarter had discordant perceived physical function and physical performance scores. Higher BMI, disease activity, depressive symptoms, and other patient-reported outcomes such as pain and fatigue were generally associated with higher risk of underreporting physical functioning relative to actual physical performance (SPPB score > PROMIS PF score), as well as with a lower risk of overreporting functioning (SPPB score < PROMIS PF score). These results suggest that physical performance, at least in terms of lower extremity mobility, may not be reliably assessed from self-reported physical function in this population.

Supporting image 1

Supporting image 2


Disclosures: L. Plantinga: None; M. Dey: None; J. Fitzpatrick: None; M. Dall'Era: AstraZeneca, 2, Aurinia, 2, Biogen, 2, Genentech, Inc., 2, GlaxoSmithKline (GSK), 2, Janssen, 2; C. Dunlop-Thomas: None; C. Hoge: None; S. Lim: Accordant, 2, AstraZeneca, 2, Biogen, 5, BMS, 5, Genentech, 2, Gilead, 5, GSK, 2, Novartis, 5, UCB, 5; C. Bowling: None; J. Yazdany: AstraZeneca, 2, Aurinia, 5, Gilead, 5; P. Katz: None.

To cite this abstract in AMA style:

Plantinga L, Dey M, Fitzpatrick J, Dall'Era M, Dunlop-Thomas C, Hoge C, Lim S, Bowling C, Yazdany J, Katz P. Concordance of Self-Reported Physical Functioning and Physical Performance in SLE: A Cross-Cohort Analysis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/concordance-of-self-reported-physical-functioning-and-physical-performance-in-sle-a-cross-cohort-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/concordance-of-self-reported-physical-functioning-and-physical-performance-in-sle-a-cross-cohort-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology